Ritonavir loaded solid lipid nanoparticles for oral drug delivery and bioavailability enhancement
Abstract Background Ritonavir is an anti-retroviral protease inhibitor to treat HIV, AIDS infections. Methods The RN-SLNs were prepared by using hot homogenization followed ultrasonication method and optimized by using a two-factor, three-level central composte design (CCD). The independent variable...
Saved in:
Main Authors: | Ananda Kumar Chettupalli, Sarad Pawar Naik Bukke, Shaik Abdul Rahaman, Aziz Unnisa, Madhumitha Adepu, Marati Kavitha, Molakpogu Ravindra Babu, Bayapa Reddy Narapureddy, Hope Onohuean |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-01-01
|
Series: | Discover Applied Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1007/s42452-024-06322-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
by: Victoria Hendrick, et al.
Published: (2024-10-01) -
Effect of quercetin on the transport of ritonavir to the central nervous system in vitro and in vivo
by: Liang Gongwen, et al.
Published: (2016-03-01) -
Comparative efficacy of repurposed drugs lopinavir-ritonavir and darunavir-ritonavir in hospitalised COVID-19 patients: insights from a tertiary centre cohort
by: Dóra Paróczai, et al.
Published: (2025-01-01) -
Screening of Polymers for Oral Ritonavir Amorphous Solid Dispersions by Film Casting
by: Ayse Nur Oktay, et al.
Published: (2024-10-01) -
Factors influencing Nirmatrelvir/Ritonavir concentration in patients with COVID-19
by: Ping Xu, et al.
Published: (2024-12-01)